Evangelos J Giamarellos-Bourboulis1, Spyridon Zakynthinos2, Fotini Baziaka3, Evangelos Papadomichelakis4, Simona Virtzili2, Pantelis Koutoukas3, Apostolos Armaganidis4, Helen Giamarellou3, Charis Roussos2. 1. Fourth Department of Internal Medicine, University of Athens Medical School, University General Hospital Attikon, 1 Rimini Str., 12464, Athens, Greece. giamarel@ath.forthnet.gr. 2. First Department of Critical Care, Evangelismos Hospital, 17 Ipsilantou Str., 11526, Athens, Greece. 3. Fourth Department of Internal Medicine, University of Athens Medical School, University General Hospital Attikon, 1 Rimini Str., 12464, Athens, Greece. 4. Second Department of Critical Care, University of Athens Medical School, University General Hospital Attikon, 1 Rimini Str., 12464, Athens, Greece.
Abstract
OBJECTIVE: To define the significance of soluble triggering receptor expressed on myeloid cells 1 (sTREM-1) in the septic cascade by comparing its kinetics to those of other proinflammatory mediators and of interleukin (IL) 10. DESIGN: Prospective study in a tertiary unit. PATIENTS: Blood was sampled from 90 patients with septic syndrome due to ventilator-associated pneumonia for 7 days after the appearance of symptoms. Concentrations of tumor necrosis factor (TNF) alpha, IL-6, IL-8, IL-10, and sTREM-1 were determined by enzyme-linked immunosorbent assay. RESULTS: Serum levels of TNFalpha, IL-6, IL-10, and sTREM-1 were higher in nonsurvivors than in survivors; similar differences were not found for IL-8. Positive correlations were found between the ratios IL-10/TNFalpha and sTREM-1/TNFalpha, between IL-10/IL-6 and sTREM-1/IL-6, and between IL-10/IL-8 and sTREM-1/IL-8. Median values of IL-10/TNFalpha upon presentation of sepsis, severe sepsis, and septic shock were 3.21, 2.16, and 2.86, respectively (NS). Respective values for sTREM-1/TNFalpha were 21.28, 7.33, and 27.78 (p=0.047 between sepsis and severe sepsis, p=0.003 between severe sepsis and septic shock). CONCLUSIONS: sTREM-1 follows the kinetics of IL-10 and should therefore be considered an anti-inflammatory mediator in sepsis. Decreased ratios of sTREM-1/TNFalpha might determine transition from sepsis to severe sepsis and from severe sepsis to septic shock.
OBJECTIVE: To define the significance of soluble triggering receptor expressed on myeloid cells 1 (sTREM-1) in the septic cascade by comparing its kinetics to those of other proinflammatory mediators and of interleukin (IL) 10. DESIGN: Prospective study in a tertiary unit. PATIENTS: Blood was sampled from 90 patients with septic syndrome due to ventilator-associated pneumonia for 7 days after the appearance of symptoms. Concentrations of tumor necrosis factor (TNF) alpha, IL-6, IL-8, IL-10, and sTREM-1 were determined by enzyme-linked immunosorbent assay. RESULTS: Serum levels of TNFalpha, IL-6, IL-10, and sTREM-1 were higher in nonsurvivors than in survivors; similar differences were not found for IL-8. Positive correlations were found between the ratios IL-10/TNFalpha and sTREM-1/TNFalpha, between IL-10/IL-6 and sTREM-1/IL-6, and between IL-10/IL-8 and sTREM-1/IL-8. Median values of IL-10/TNFalpha upon presentation of sepsis, severe sepsis, and septic shock were 3.21, 2.16, and 2.86, respectively (NS). Respective values for sTREM-1/TNFalpha were 21.28, 7.33, and 27.78 (p=0.047 between sepsis and severe sepsis, p=0.003 between severe sepsis and septic shock). CONCLUSIONS: sTREM-1 follows the kinetics of IL-10 and should therefore be considered an anti-inflammatory mediator in sepsis. Decreased ratios of sTREM-1/TNFalpha might determine transition from sepsis to severe sepsis and from severe sepsis to septic shock.
Authors: J Rello; J A Paiva; J Baraibar; F Barcenilla; M Bodi; D Castander; H Correa; E Diaz; J Garnacho; M Llorio; M Rios; A Rodriguez; J Solé-Violán Journal: Chest Date: 2001-09 Impact factor: 9.410
Authors: Spaska A Stanilova; Zhivko T Karakolev; Gospodin S Dimov; Zlatka G Dobreva; Lyuba D Miteva; Emil S Slavov; Chavdar S Stefanov; Noyko S Stanilov Journal: Intensive Care Med Date: 2005-02-18 Impact factor: 17.440
Authors: Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay Journal: Crit Care Med Date: 2003-04 Impact factor: 7.598
Authors: C Routsi; E J Giamarellos-Bourboulis; A Antonopoulou; S Kollias; S Siasiakou; A Koronaios; S Zakynthinos; A Armaganidis; H Giamarellou; C Roussos Journal: Clin Exp Immunol Date: 2005-10 Impact factor: 4.330
Authors: M Raftogiannis; A Antonopoulou; F Baziaka; A Spyridaki; P Koutoukas; T Tsaganos; A Savva; A Pistiki; M Georgitsi; E J Giamarellos-Bourboulis Journal: Clin Exp Immunol Date: 2010-09 Impact factor: 4.330
Authors: Peter Andrews; Elie Azoulay; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Daniel De Backer; Geoffrey Dobb; Jean-Yves Fagon; Herwig Gerlach; Johan Groeneveld; Duncan Macrae; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Jerôme Pugin; Michael Pinsky; Peter Radermacher; Christian Richard Journal: Intensive Care Med Date: 2006-12-19 Impact factor: 17.440
Authors: Bart Ferwerda; Matthew B B McCall; Santos Alonso; Evangelos J Giamarellos-Bourboulis; Maria Mouktaroudi; Neskuts Izagirre; Din Syafruddin; Gibson Kibiki; Tudor Cristea; Anneke Hijmans; Lutz Hamann; Shoshana Israel; Gehad ElGhazali; Marita Troye-Blomberg; Oliver Kumpf; Boubacar Maiga; Amagana Dolo; Ogobara Doumbo; Cornelus C Hermsen; Anton F H Stalenhoef; Reinout van Crevel; Han G Brunner; Djin-Ye Oh; Ralf R Schumann; Concepcion de la Rúa; Robert Sauerwein; Bart-Jan Kullberg; André J A M van der Ven; Jos W M van der Meer; Mihai G Netea Journal: Proc Natl Acad Sci U S A Date: 2007-10-09 Impact factor: 11.205